Literature DB >> 18472866

Pulmonary hypertension in infants with congenital heart defects: are leukotrienes involved?

A Serraf1, J P Gascard, J Bruniaux, C Labat, C Planche, C Brink.   

Abstract

The circulating levels of leukotriene E4 in infants with congenital heart defects, increased pulmonary blood flow and pulmonary arterial hypertension, were determined and compared with infants with decreased pulmonary blood flow (Tetralogy of Fallot). There was no correlation (r=0.38) between the pulmonary arterial pressure (56+/-4 mmHg) and the leukotriene E4 levels (1.37+/-0.67 ng/ml blood) measured in peripheral blood samples from the hypertensive group prior to surgery. There was considerable variation in the detectable leukotriene E4 levels in blood samples from different patients. The levels detected in the blood samples between the two groups of patients was similar. These data suggest that neither the surgical repair during cardiopulmonary bypass nor the pulmonary hypertension appeared to modify the leukotriene E4 blood levels in the small number of patients studied.

Entities:  

Year:  1997        PMID: 18472866      PMCID: PMC2365871          DOI: 10.1080/09629359791451

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  15 in total

1.  Leukotrienes in the blood and urine of children with acute asthma.

Authors:  A P Sampson; C P Green; D A Spencer; P J Piper; J F Price
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

2.  Cysteinyl leukotriene involvement in chronic lung disease in premature infants.

Authors:  A J Cook; B Yuksel; A P Sampson; A Greenough; J F Price
Journal:  Eur Respir J       Date:  1996-09       Impact factor: 16.671

3.  Critical considerations in the development of an assay for sulfidopeptide leukotrienes in plasma.

Authors:  D J Heavey; R J Soberman; R A Lewis; B Spur; K F Austen
Journal:  Prostaglandins       Date:  1987-05

4.  Alveolar transfer and metabolism of eicosanoids in the rat.

Authors:  J Y Westcott; T J McDonnell; N F Voelkel
Journal:  Am Rev Respir Dis       Date:  1989-01

5.  Identification of lipoxin A4 and its relationship to the sulfidopeptide leukotrienes C4, D4, and E4 in the bronchoalveolar lavage fluids obtained from patients with selected pulmonary diseases.

Authors:  T H Lee; A E Crea; V Gant; B W Spur; B E Marron; K C Nicolaou; E Reardon; M Brezinski; C N Serhan
Journal:  Am Rev Respir Dis       Date:  1990-06

6.  Characteristics of formation and further metabolism of leukotrienes in the chopped human lung.

Authors:  M Kumlin; S E Dahlén
Journal:  Biochim Biophys Acta       Date:  1990-05-22

7.  Urinary leukotriene E4 levels during early and late asthmatic responses.

Authors:  P J Manning; J Rokach; J L Malo; D Ethier; A Cartier; Y Girard; S Charleson; P M O'Byrne
Journal:  J Allergy Clin Immunol       Date:  1990-08       Impact factor: 10.793

8.  A second cysteinyl leukotriene receptor in human lung.

Authors:  C Labat; J L Ortiz; X Norel; I Gorenne; J Verley; T S Abram; N J Cuthbert; S R Tudhope; P Norman; P Gardiner
Journal:  J Pharmacol Exp Ther       Date:  1992-11       Impact factor: 4.030

9.  Persistent generation of peptido leukotrienes in patients with the adult respiratory distress syndrome.

Authors:  G R Bernard; V Korley; P Chee; B Swindell; A W Ford-Hutchinson; P Tagari
Journal:  Am Rev Respir Dis       Date:  1991-08

10.  The differential effects of leukotriene C4 and D4 on the pulmonary and systemic circulations in newborn lambs.

Authors:  M D Schreiber; M A Heymann; S J Soifer
Journal:  Pediatr Res       Date:  1987-02       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.